Vimarsana
Biggest News Aggregation in the World

Page 5 - Kumar Budur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kumar Budur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kumar Budur Today - Breaking & Trending Today

Pitolisant Gets Orphan Drug Status for Idiopathic Hypersomnia - Vimarsana News

Pitolisant Gets Orphan Drug Status for Idiopathic Hypersomnia

The Food and Drug Administration (FDA) has granted Orphan Drug designation to pitolisant for the treatment of idiopathic hypersomnia. 

Pitolisant Shows Promise for Prader-Willi Syndrome Symptoms - Vimarsana News

Pitolisant Shows Promise for Prader-Willi Syndrome Symptoms

Harmony announced new data from its phase 2 study evaluating pitolisant for excessive daytime sleepiness in Prader-Willi syndrome.

HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME - Vimarsana News

HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

Pitolisant Gets Orphan Drug Status for Idiopathic Hypersomnia - Vimarsana News

Pitolisant Gets Orphan Drug Status for Idiopathic Hypersomnia

The FDA has granted Orphan Drug designation to pitolisant for the treatment of idiopathic hypersomnia.

Harmony Gets Orphan Drug Designation for Pitolisant for IH - Vimarsana News

Harmony Gets Orphan Drug Designation for Pitolisant for IH

The FDA has granted Harmony Biosciences Orphan Drug Designation for pitolisant for the treatment of idiopathic hypersomnia.